I disagree in the sense that NP is *very* careful

I disagree in the sense that NP is *very* careful when it comes to how he phrases anything connected to FDA. For instance, NASH he can say whatever he wants or share price, but when it comes to HIV or cancer data he’s careful bc that’s what the FDA is looking at.

I also think there’s a good chance FDA will approve sooner than most expect bc this is a drug with ZERO serious side effects and it’s saving lives. Give me one good comp for a drug in a similar scenario...